{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2020"],"condition":["Diseases of the digestive system"],"disease":["Diseases Of The Digestive System"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2512718"],"location":["South Korea"],"study_start_month":["4"],"repository":["ECRIN MDR"],"study_status":["Not yet recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy and Safety of Bojungikgi-tang for Anorexia in Patients with Colorectal Cancer after Curative Resection and Chemotherapy : A single-arm, Open label, Single cencer Trial","description":"Interventions: Drug : Participants will be administered Hanpoong Bojungikgi-tang at a dose of 75ml three times a day before or between meals for 6 weeks(42days)\nPrimary outcome(s): The Changes of Anorexia/cachexia subscale(A/CS) of Functional Assessment of Anorexia/Cachexia Therapy(FAACT)","dates":{"creation":"2020-04-15"},"accession":"2512718","cross_references":{"Clinical Research Information Service":["KCT0004785"]}}